Evasc Neurovascular

Evasc is a medical device company focused on developing novel medical devices for the endovascular repair of cerebral aneurysms, aiming to provide a higher standard of care and successful treatment outcome rates than before. In 2013, Evasc received approval for the use of eCLIPs in Canada under the Special Access Program, and obtained CE Mark approval in 2015. The eCLIPs technology is protected by multiple patents and designed to treat 95% of cerebral aneurysms, including the most challenging wide-neck bifurcations.